Usagainstalzheimer's
Non-Profit & Charitable Organizations · District of Columbia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1101 K St NW Ste 400, Washington, Distri...Phone Number
(202) 349-3803Website
www.usagainstalzheimers.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Usagainstalzheimer's
UsAgainstAlzheimer's (UsA2) is a disruptive advocacy and research-focused organization that is pushing for expanding treatments and accelerating towards a cure for Alzheimer's disease. UsA2's transformative programming is laser-focused on proactive brain health across the lifespan and understanding what matters most across the lived experiences of those affected by Alzheimer's in the service of preventing, treating and curing this disease. The company is working to ensure that all communities have their voices heard and get a chance to be brain healthy from the earliest years while building resistance against possible cognitive decline.Explore more
Usagainstalzheimer's Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Usagainstalzheimer's your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Usagainstalzheimer's had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Usagainstalzheimer's recently announced quarterly report
Check out if Usagainstalzheimer's is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Usagainstalzheimer's
Product Launch: Get notified when Usagainstalzheimer's launches new products
Check if Usagainstalzheimer's has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Usagainstalzheimer's has new funding data
Usagainstalzheimer's, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Usagainstalzheimer's
Find 2 more new buyers
Compare Similar Companies to Usagainstalzheimer's
Compare insights from companies similar to Usagainstalzheimer's, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Usagainstalzheimer's is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Usagainstalzheimer's is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Usagainstalzheimer's.
Usagainstalzheimer's Tech Stack
A closer look at the technologies used by Usagainstalzheimer's
Most Recent Scoops
Left Company
Executive Move
Russell (Russ) Paulsen, President & Chief Operating Officer, has recently left the organization and now serves as Chief Executive Officer for Research!America, Discovery. Innovation. Health..
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Project
, according to a high-level source in medical, is planning to leverage AI-driven document drafting over the next six to twelve months.
Artificial Intelligence
Project
Automation, Artificial Intelligence
Usagainstalzheimer's News & Media
Organizations Unite to Improve Brain Health
UsAgainstAlzheimer’s Launches Business Collaborative for Brain Health with founding partners AARP, GN Group, Eli Lilly, and Novo Nordisk, to improve brain health in the workforce. UsAgainstAlzheimer’s Launches Business Collaborative for Brain Health with founding partners AARP, GN Group, Eli Lilly, and Novo Nordisk, to improve brain health in the workforce.Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
The event furthered discussions on ensuring recent scientific breakthroughs benefit patients. The event furthered discussions on ensuring recent scientific breakthroughs benefit patients.UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
Medicare must now provide coverage for patients Medicare must now provide coverage for patientsSen. Collins, Rep. Eshoo Decry Medicare Coverage Rejection of Alzheimer’s Drugs
“It’s not CMS’ job to deny the use under the Medicare program of an FDA-approved drug.” – Sen. Susan Collins; “…breakthroughs have to reach people, otherwise it really doesn’t mean a darn thing to them.” – Rep. Anna Eshoo “It’s not CMS’ job to deny the use under the Medicare program of an FDA-approved drug.” – Sen. Susan Collins; “…breakthroughs have to reach people, otherwise it really doesn’t mean a darn thing to them.” –
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Usagainstalzheimer's
Sign Up For FreeTo access detailed company insights
UsAgainstAlzheimer's (UsA2) is a disruptive advocacy and research-focused organization that is pushing for expanding treatments and accelerating towards a cure for Alzheimer's disease. UsA2's transformative programming is laser-focused on proactive brain health across the lifespan and understanding what matters most across the lived experiences of... Read More
